Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
10:01pm, Wednesday, 24'th Apr 2024
The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
07:01pm, Wednesday, 24'th Apr 2024
Amedisys (AMED) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1 per share a year ago.
Amedisys Reports First Quarter 2024 Financial Results
04:45pm, Wednesday, 24'th Apr 2024
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.
Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
11:07am, Wednesday, 24'th Apr 2024
Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Amedisys (AMED) is a Strong Value Stock
10:46am, Tuesday, 23'rd Apr 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Amedisys (AMED) is a Top Value Stock for the Long-Term
10:46am, Monday, 25'th Mar 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Amedisys (AMED) Down 2.5% Since Last Earnings Report?
12:36pm, Friday, 22'nd Mar 2024
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
How Amedisys (AMED) Stock Stands Out in a Strong Industry
10:01am, Wednesday, 20'th Mar 2024
Amedisys (AMED) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys
06:16pm, Tuesday, 19'th Mar 2024
Amedisys said on Tuesday Oregon's health authority has started a review of UnitedHealth Group's $3.3 billion acquisition of the home health and hospice caregiver.
Amedisys' (AMED) Q4 Earnings Miss Estimates, Margins Up
12:35pm, Friday, 23'rd Feb 2024
The continuous shortage of clinical labor, nursing in particular, is likely to have impacted Amedisys' (AMED) Q4 performance.
AMED vs. USPH: Which Stock Is the Better Value Option?
12:41pm, Thursday, 22'nd Feb 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
09:01pm, Wednesday, 21'st Feb 2024
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compa
Amedisys (AMED) Q4 Earnings Lag Estimates
07:01pm, Wednesday, 21'st Feb 2024
Amedisys (AMED) came out with quarterly earnings of $0.94 per share, missing the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.16 per share a year ago.
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
04:30pm, Wednesday, 21'st Feb 2024
BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.
Amedisys (AMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:06am, Wednesday, 14'th Feb 2024
Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
